Navigation Links
Sam Safran wins EPJE -- Pierre-Gilles De Gennes Lecture Prize
Date:7/2/2010

Sam Safran, a professor at the Weizmann Institute in Israel, has been chosen as the recipient of the first EPJE - Pierre-Gilles De Gennes Lecture Prize. The prize, accompanied by 1,000, is being awarded by Springer's European Physical Journal E (EPJE). Safran is the author of numerous articles in this journal.

The EPJE - Pierre-Gilles De Gennes Lecture Prize, which was named after the Nobel laureate who founded EPJE, has been awarded to Safran to recognize his leading research in soft matter and biological physics. The prizewinner has been invited to give a lecture at the International Soft Matter Conference 2010 in Granada, Spain. The prize will be presented to Safran at the beginning of his plenary talk on 6 July 2010.

In addition to serving as a professor at the Wiezmann Institute, Safran also served as Vice President and Dean of its Graduate School. From 1980-1990 he was at the Exxon Corporate Research Labs where he worked on the theory of soft matter with a focus on the structure and phase behavior of oil-water-surfactant dispersions. His recent research interests have extended soft matter concepts to treat biological membranes and cells. Safran is a recipient of the Beller Lectureship Award of the American Physical Society and the Lectureship Award of the Japanese Chemical Society.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1

Related biology news :

1. SAFRAN to Acquire Motorolas Biometrics Business
2. Dr. George Stark receives 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship from ASBMB
3. Public lecture to explore solutions to the food challenge
4. Public lecture at UC Riverside to highlight Californias environment
5. Vilcek Prize lecture
6. UC Riverside lecture: Climate change, bark beetles, environmental markets and sustainability
7. A rocking good lecture
8. Nobel Laureate Roger Tsien to present national lecture at the Biophysical Society meeting
9. Nobel laureate claims the 2010 Herbert Tabor Lectureship
10. Plenary lecturers share science and policy perspectives
11. Evolution of hyperactivity is focus of free public lecture at UC Riverside
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... SEATTLE , Nov. 30, 2016  The ... Allen Cell Collection: the first publicly available collection ... stem cells that target key cellular structures with ... Medical Research, these powerful tools are a crucial ... cells to better understand what makes human cells ...
(Date:11/30/2016)... November 2016   Merck , ein ... Unterzeichnung einer Reihe von Vereinbarungen mit Evotec ... AG Screeningleistungen für Mercks Palette genetischer Reagenzien ... auf diese Bibliotheken in Kombination mit Evotecs ... Weg zur Ermittlung und Erforschung neuer Arzneimitteltargets.    ...
(Date:11/30/2016)... Woburn, MA (PRWEB) , ... November 30, 2016 ... ... broadband light sources for advanced technology applications, introduces the 5th generation, ultra-bright, Laser-Driven ... the highly successful Laser-Driven Light Source (LDLS™) technology, the EQ-77 offers higher radiance ...
(Date:11/30/2016)... ... 30, 2016 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), ... today announced that all five of its validated monoclonal antibody (mAb) therapeutic candidates ... prion-like forms of Amyloid beta (Aß) in vitro. , “We previously demonstrated that ...
Breaking Biology Technology: